[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100377136":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":16,"centralContacts":21,"locations":27,"responsibleParty":90,"collaborators":7,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":94,"sex":100,"minAge":101,"maxAge":7,"enrollmentInfo":102,"targetDuration":105,"studyType":106,"phases":7,"briefSummary":107,"conditions":108,"keywords":114,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"NeoChord","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DEVICE","NeoChord Artificial Chordae Delivery System, Model DS1000","The intended use of the device is for the placement of artificial chordae when the natural chordae tendinae have become elongated or ruptured due to degenerative valve disease.",[14,15],"NeoChord DS1000","DS1000",[17],{"name":18,"affiliation":19,"role":20},"Andres Beiras Fernandez, MD PhD","Johannes Gutenberg University Mainz","PRINCIPAL_INVESTIGATOR",[22],{"name":23,"role":24,"phone":25,"phoneExt":7,"email":26},"Alexandar Jonkers","CONTACT","+31 610740977","ajonkers@neochord.com",[28,43,54,64,77],{"facility":29,"status":30,"city":31,"state":7,"zip":7,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University of Bonn","RECRUITING","Bonn","Germany","DE",{"type":35,"coordinates":36},"Point",[37,38],7.09549,50.73438,{"lat":38,"lon":37},[41],{"name":42,"role":20,"phone":7,"phoneExt":7,"email":7},"Georg Nickenig, MD",{"facility":44,"status":30,"city":45,"state":7,"zip":7,"country":32,"countryCode":33,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"CVC Frankfurt","Frankfurt",{"type":35,"coordinates":47},[48,49],10.53333,49.68333,{"lat":49,"lon":48},[52],{"name":53,"role":20,"phone":7,"phoneExt":7,"email":7},"Horst Sievert, MD PhD",{"facility":55,"status":30,"city":56,"state":7,"zip":7,"country":32,"countryCode":33,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"University of Mainz","Mainz",{"type":35,"coordinates":58},[59,60],8.28008,49.98185,{"lat":60,"lon":59},[63],{"name":18,"role":20,"phone":7,"phoneExt":7,"email":7},{"facility":65,"status":30,"city":66,"state":7,"zip":7,"country":67,"countryCode":68,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Hippokration Hospital","Athens","Greece","GR",{"type":35,"coordinates":70},[71,72],23.72784,37.98376,{"lat":72,"lon":71},[75],{"name":76,"role":20,"phone":7,"phoneExt":7,"email":7},"Vasileios Lozos, MD",{"facility":78,"status":30,"city":79,"state":7,"zip":7,"country":80,"countryCode":81,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Triemli Hospital","Zurich","Switzerland","CH",{"type":35,"coordinates":83},[84,85],8.55,47.36667,{"lat":85,"lon":84},[88],{"name":89,"role":20,"phone":7,"phoneExt":7,"email":7},"Omer Dzemali, MD",{"type":91,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100377136","multicenter-post-market-observational-registry-of-the-neochord-artificial-chordae-delivery-system-100377136",false,"NCT04190602","Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System","The AcChord Study: A Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System","AcChord","Inclusion Criteria:\n\n* Has Grade III Moderate or Grade IV Severe degenerative or mixed disease mitral valve regurgitation\n* Study procedure completed after 31 December 2016\n\nExclusion Criteria:\n\n* Heavily calcified valves\n* Valvular retraction with severely reduced mobility\n* Active bacterial endocarditis\n* Complex mechanism of MR (leaflet perforation, etc.)\n* Significant tethering of leaflets\n* Inflammatory valve disease","ALL","18 Years",{"count":103,"type":104},500,"ESTIMATED","5 Years","OBSERVATIONAL","The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.",[109,110,111,112,113],"Mitral Regurgitation","Mitral Valve Disease","Mitral Valve Insufficiency","Mitral Valve Prolapse","Heart Valve Diseases",[5,15,115,116],"Artificial Chordae","Mitral Valve Repair","2020-07-09",{"date":119,"type":120},"2020-07-10","ACTUAL",{"date":122,"type":120},"2020-02-09",{"date":124,"type":104},"2027-12",{"name":5,"class":6},5]